Drug intelligence / Profile preview

neohesperidin

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Neohesperidin is a naturally occurring flavanone glycoside found predominantly in the peels of citrus fruits such as bitter orange and sour orange. It exhibits significant **antioxidant** and **anti-inflammatory** properties, with reported therapeutic potential in bone health (including osteoporosis and osteoarthritis), lipid metabolism, and glucose regulation. Mechanistically, it inhibits osteoclastogenesis and NF-κB/NFAT activation, suppresses inflammatory cytokines and matrix metalloproteinases, and improves glucose tolerance while reducing insulin resistance and hyperlipidemia in preclinical models. It is also a precursor to neohesperidin dihydrochalcone (NHDC), an artificial sweetener produced by hydrogenating neohesperidin. Neohesperidin has roles as an antineoplastic agent, hypolipidemic agent, antioxidant, and plant metabolite[1][4][6].

Other names
Hesperetin 7-neohesperidosideHesperetin7-neohesperidosideHesperetin-7-neohesperidosideHesperetin 7-O-neohesperidosideHesperetin7-O-neohesperidosideHesperetin-7-O-neohesperidoside
02

Targets

JNK (Mitogen-activated protein kinase kinase kinase family)AMPK (Adenosine monophosphate–activated protein kinase)NFATC1RBD (SARS-CoV-2 spike receptor-binding domain)NF-κB

Beyond the preview

Go deeper on neohesperidin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on neohesperidin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call